EDITAS MEDICINE, INC. Gain (Loss) on Disposition of Property Plant Equipment
EDITAS MEDICINE, INC. (EDIT) reported Gain (Loss) on Disposition of Property Plant Equipment of -$111.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnSaleOfPropertyPlantEquipment · last filed 2026-08-05
- EDITAS MEDICINE, INC. gain (loss) on disposition of property plant equipment for the quarter ending 2025-12-31 was $0.00.
- EDITAS MEDICINE, INC. gain (loss) on disposition of property plant equipment for the quarter ending 2025-09-30 was $0.00.
- EDITAS MEDICINE, INC. gain (loss) on disposition of property plant equipment for the quarter ending 2024-12-31 was -$10.00K, a 100.63% decline year-over-year.
- EDITAS MEDICINE, INC. gain (loss) on disposition of property plant equipment for the quarter ending 2024-09-30 was -$139.00K.
- EDITAS MEDICINE, INC. gain (loss) on disposition of property plant equipment for fiscal 2025 was -$2.19M.
- EDITAS MEDICINE, INC. gain (loss) on disposition of property plant equipment for fiscal 2024 was -$149.00K.
- EDITAS MEDICINE, INC. gain (loss) on disposition of property plant equipment for fiscal 2023 was $0.00.
- EDITAS MEDICINE, INC. gain (loss) on disposition of property plant equipment for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment 3 month | Gain (Loss) on Disposition of Property Plant Equipment 6 month | Gain (Loss) on Disposition of Property Plant Equipment 9 month | Gain (Loss) on Disposition of Property Plant Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$111.00K 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | -$2.19M 10-K · filed 2026-03-09 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.19M 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | -$2.19M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$149.00K derived: sum of 2 quarters · filed 2026-03-09 | -$149.00K derived: sum of 3 quarters · filed 2026-03-09 | -$149.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | -$139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$139.00K derived: sum of 2 quarters · filed 2025-11-10 | -$139.00K 10-Q · filed 2025-11-10 | $1.44M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $1.58M derived: sum of 3 quarters · filed 2025-08-12 | $1.58M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | $1.58M derived: sum of 2 quarters · filed 2025-03-05 | $1.58M derived: sum of 3 quarters · filed 2025-03-05 | $1.58M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $1.58M derived: sum of 2 quarters · filed 2025-03-05 | $1.58M derived: sum of 3 quarters · filed 2025-03-05 | $0.00 10-K · filed 2025-03-05 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $0.00 derived: sum of 2 quarters · filed 2024-11-04 | -$1.58M 10-Q · filed 2024-11-04 | -$1.58M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$1.58M 10-Q · filed 2024-08-07 | -$1.58M derived: sum of 3 quarters · filed 2025-03-05 | |
| 2023-03-31 | -$1.58M 10-Q · filed 2024-05-08 | -$1.58M derived: sum of 2 quarters · filed 2025-03-05 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $0.00 10-K · filed 2025-03-05 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |